Maravai LifeSciences Holdings, Inc.
MRVI · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $186M | $259M | −28.3% |
| Operating income | −$215M | −$236M | +8.6% |
| Net income | −$131M | −$145M | +9.7% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 5, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $45.9M | $41.6M | +10.3% |
| Operating income | −$20.6M | −$41.0M | +49.8% |
| Net income | −$13.8M | −$25.6M | +46.1% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Maravai LifeSciences's revenue in FY2025?
- $186M in FY2025 (Fiscal year ended Dec 31, 2025), −28.3% vs $259M a year earlier, per its 10-K filed Feb 2026.
- Was Maravai LifeSciences profitable in FY2025?
- No: net income was −$131M and operating income −$215M in FY2025.
- What was Maravai LifeSciences's revenue in Q3 2026?
- $45.9M (+10.3% vs a year earlier), per its Form 10-Q filed Nov 5, 2026.